para‐Nitroblebbistatin, the Non‐Cytotoxic and Photostable Myosin II Inhibitor M Képiró, BH Várkuti, L Végner, G Vörös, G Hegyi, M Varga, ... Angewandte Chemie International Edition 53 (31), 8211-8215, 2014 | 137 | 2014 |
A highly soluble, non-phototoxic, non-fluorescent blebbistatin derivative BH Várkuti, M Képiró, IÁ Horváth, L Végner, S Ráti, Á Zsigmond, G Hegyi, ... Scientific reports 6 (1), 26141, 2016 | 124 | 2016 |
Azidoblebbistatin, a photoreactive myosin inhibitor M Képiró, BH Várkuti, A Bodor, G Hegyi, L Drahos, M Kovács, ... Proceedings of the National Academy of Sciences 109 (24), 9402-9407, 2012 | 50 | 2012 |
Identification of natural target proteins indicates functions of a serralysin-type metalloprotease, PrtA, in anti-immune mechanisms G Felföldi, J Marokházi, M Képiró, I Venekei Applied and environmental microbiology 75 (10), 3120-3126, 2009 | 42 | 2009 |
Neuron-based high-content assay and screen for CNS active mitotherapeutics BH Varkuti, M Kepiro, Z Liu, K Vick, Y Avchalumov, R Pacifico, ... Science advances 6 (2), eaaw8702, 2020 | 30 | 2020 |
High-throughput small molecule screen identifies modulators of mitochondrial function in neurons BH Varkuti, Z Liu, M Kepiro, R Pacifico, Y Gai, T Kamenecka, RL Davis IScience 23 (3), 2020 | 14 | 2020 |
Molecular tattoo: subcellular confinement of drug effects M Képiró, BH Várkuti, AA Rauscher, MSZ Kellermayer, M Varga, ... Chemistry & biology 22 (4), 548-558, 2015 | 11 | 2015 |
Effect of allosteric inhibition of non-muscle myosin 2 on its intracellular diffusion ÁI Horváth, M Gyimesi, BH Várkuti, M Képiró, G Szegvári, I Lőrincz, ... Scientific Reports 10 (1), 13341, 2020 | 9 | 2020 |
High content, phenotypic assays and screens for compounds modulating cellular processes in primary neurons M Kepiro, BH Varkuti, RL Davis Methods in enzymology 610, 219-250, 2018 | 9 | 2018 |
Azidation technology: from photoaffinity labeling to molecular tattooing M Kepiro PhD Thesis 2014, Eotvos Lorand University, Budapest, Hungary, 2014 | 5 | 2014 |
Water-soluble myosin 2 inhibitors for the treatment of neurological, neuropathic or psychiatric diseases Z Lenkei, AM CSIZMADIA, M Képiró, B Várkuti US Patent 10,858,357, 2020 | 2 | 2020 |
Mitotherapeutics for the treatment of brain disorders RL Davis, Z Liu, BH Varkuti, M Kepiro, CM Macmullen US Patent App. 17/756,842, 2023 | | 2023 |
The role of NM2 rearrangement during cytokinesis AI Horvath, M Gyimesi, M Kepiro, B Varkuti, A Malnasi-Csizmadia Biophysical Journal 121 (3), 259a-260a, 2022 | | 2022 |
Molecular Tattoo: Subcellular Confinement of Drug Effects In Vivo with Two-Photon Microscopy B Várkuti, M Képiró, AÁ Rauscher, L Végner, Á Zsigmond, V Imrich, S Ráti, ... Biophysical Journal 112 (3), 149a-150a, 2017 | | 2017 |
Subcellular Spatial Control of Non-Muscle Myosin 2 Redistribution and Stress Fiber Strain by Molecular Tattoo AI Horvath, BH Varkuti, M Kepiro, G Hegyi, M Kovacs, ... Biophysical Journal 112 (3), 430a, 2017 | | 2017 |
Highly Soluble, Non-Phototoxic, Non-Fluorescent, Photostable Blebbistatin Derivatives AÁ Rauscher, S Kumar, BH Várkuti, M Képiró, ÁI Horváth, L Végner, ... Biophysical Journal 112 (3), 266a-267a, 2017 | | 2017 |
Molecular Tattooing of Live Cells and Animals: Spatial and Time Specific Effects of Azidoblebbistatin by Two-Photon Microscopy M Kepiro, B Varkuti, G Hegyi, MSZ Kellermayer, MC Andras Biophysical Journal 106 (2), 177a, 2014 | | 2014 |
Interactomics of Blebbistatin M Képiró, BH Várkuti, G Hegyi, M Kovács, A Málnási-Csizmadia Biophysical Journal 104 (2), 403a-404a, 2013 | | 2013 |
Structural Model of the Pre-Powerstroke State of the Actomyosin Complex Y Zhenhui, B Varkuti, A Rauscher, M Kepiro, A Malnasi-Csizmadia Biophysical Journal 102 (3), 16a, 2012 | | 2012 |
Synthesis and Functional Characterization of Azido-Blebbistatin, a Photoreactive Myosin Inhibitor M Képiró, BH Várkuti, G Hegyi, M Kovács, A Málnási-Csizmadia Biophysical Journal 102 (3), 159a, 2012 | | 2012 |